Results 61 to 70 of about 51,719 (196)

Clinical pharmacology of cefotaxime in pediatric patients

, 1981
Cefotaxime is a new cephalosporin with a spectrum of activity which may make it appropriate for use in pediatric patients. In 33 infants and children, administration of cefotaxime resulted in cure or improvement in 97% of patients, with eradication of 94%
Papadatos, C.J., Kafetzis, D.A., Brater, D.C., Sinaniotis, C.A., Kanarios, J.   +4 more
core   +1 more source

Dosing Regimen for Cefotaxime Should Be Adapted to the Stage of Renal Dysfunction in Critically Ill Adult Patients—A Retrospective Study

Antibiotics
Cefotaxime administration is recommended in doses of 3–12 g/day in adults with a Glomerular Filtration Rate (GFR) > 5 mL/min. This study aimed to assess the impact of renal function and obesity on cefotaxime concentrations in intensive care unit (ICU ...
Théo Dillies, Sophie Perinel-Ragey, Patricia Correia, Jérôme Morel, Guillaume Thiery, Manon Launay   +5 more
doaj   +1 more source

Efficacy of delafloxacin alone and in combination with cefotaxime against cefotaxime non-susceptible invasive isolates of Streptococcus pneumonia

OBJECTIVES: We assessed the in vitro activity of delafloxacin and the synergy between cefotaxime and delafloxacin among cefotaxime non-susceptible invasive isolates of Streptococcus pneumoniae (CNSSP).
Pérez, M, Delgado-Iribarren, Alberto, Sanz, J C, Ríos, Esther, Delgado-Iribarren, A, Sanz, Juan Carlos, Rodríguez-Avial, Iciar, Ríos, E, Rodríguez-Avial, I, Pérez, Marta   +9 more
core   +1 more source

Cefotaxime resistance in cattle.

, 2016
The prevalence of cefotaxime resistant bacteria isolated from eight cattle herds housed at three farms located in North-Central Florida is presented with 95% confidence intervals, along with the total prevalence.
Douglas Archer (3126969), J. Glenn Morris Jr (380495), Thomas A. Weppelmann (659325), KwangCheol Casey Jeong (2156968), Raies A. Mir (2156971), Judith A. Johnson (442836)   +5 more
core   +1 more source

Ceftazidime and cefotaxime--the clinician's choice.

, 1989
A review of two third-generation cephalosporins, ceftazidime and cefotaxime, is presented. Ceftazidime, often used as a single agent, has shown greater activity than cefotaxime against Pseudomonas aeruginosa and other Pseudomonas species ...
Puthucheary, S.D., Goldsworthy, P.J.
core  

Emergence of CTX-M group 1 extended-spectrum ß-lactamase–producing Klebsiella pneumoniae strains in the community [PDF]

Medicinski Glasnik, 2010
Aim Molecular characterization of ESBL-producing K. pneumoniaestrains isolated from urine of outpatients in Zagreb regionduring the last five years. Methods During the five-year study period a total of 2, 651 K.pneumoniae strains were isolated from urine
Nataša Beader,, Maja Anušić,, Jasna Knežević,, Tamara Kukovec,, Ana Mlinarić-Džepina,, Tatjana Marijan,, Zrinka Bošnjak,, Jasmina Vraneš,, Branka Bedenić,, Petra Barl,, Vladimira Leskovar,, Smilja Kalenić,   +11 more
doaj  

Effectiveness of cefotaxime in gram-negative meningitis.

, 1984
We treated 12 adult patients who had gram-negative bacillary meningitis with cefotaxime administered intravenously at a dose of 2 g every 4 hours.
Henao, L, LeFrock, J L, Smith, B, Rosenberg, M, Black, P, Chandrasekar, P, Rolston, K, Kannangara, D W, Brodner, R, Molavi, A   +9 more
core   +1 more source

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics

Антибиотики и Химиотерапия, 2020
A new inhibitor-protected beta-lactam antibiotic has been registered in Russia, a fixed combination of antistreptococcal cephalosporin III, cefotaxime and inhibitor of beta-lactamase sulbactam in a 2:1 ratio.
S. V. Yakovlev, M. P. Suvorova
doaj  

Possible cefotaxime-induced Stevens-Johnson syndrome

, 2003
OBJECTIVE: To report a case of possible cefotaxime-induced Stevens-Johnson syndrome (SJS). CASE SUMMARY: A 72-year-old woman with an upper urinary tract infection developed erosions and blisters on the skin and the mucous membranes, as well as fever and ...
Elisaf, M. S., Liberopoulos, E. N., Liamis, G. L.   +2 more
core  

Residue definitions for meropenem and cefotaxime acylenzymes

, 2017
Modified GROMACS aminoacids.rtp file for AMBER99SB-ILDN force field containing residue definitions for serine-meropenem adducts and serine-cefotaxime ...
Cortina, George A., Peter Kasson (8031431), Kasson, Peter, George A. Cortina (7220720)   +3 more
core   +1 more source